Investors / Germany / Wellington Partners
Wellington Partners
Venture capital · Munich, Germany · Europe
Wellington Partners is a European venture capital firm that invests in early- and growth-stage life science companies. It provides financing and board-level strategic support to portfolio companies, with ticket sizes typically between EUR 2 million and EUR 20 million.
Invests inHealthcare & Biotech
In its own wordslife sciencesbiotechnologytherapeuticsmedical devicesdiagnosticsdigital health
Your fit with Wellington Partners
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsWellington Partners lists 22 checked portfolio companies on its own site and is named in 5 funding rounds. Its most frequent entry is Series B, 60% of the companies with a known first round. Its largest themes are Healthcare & Biotech (91%), Legal & Compliance (4%) and E-commerce & Marketplaces (4%). 42% of its companies are based in Germany. It invests most often alongside MIG Capital, b2venture and 415 Capital.
Counts come from funding rounds that name Wellington Partners, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Wellington Partners' whole history. Rounds on record name 5 companies; its own site lists 22. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 20% |
| Series B | 60% |
| Growth | 20% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 1 | 0 |
| '25 | 2 | 0 |
| '26 | 2 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 55th | 22 companies |
| Recent activity | 69th | 2 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 84th | 14% of companies confirmed by a round |
| Sector focus | 96th | 91% in its largest sector |
| Reach | 88th | 7 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| MIG Capital | 3 |
| b2venture | 3 |
| 415 Capital | 2 |
| Angelini Ventures | 2 |
| Eisai Innovation Inc. | 2 |
| Kurma Partners | 2 |
| 15th Rock | 1 |
| Adjuvant Capital | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers22100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 91% | 15% |
| Legal & Compliance | 4% | 2% |
| E-commerce & Marketplaces | 4% | 6% |
Co-investor network
who it backs companies with, and who they back togetherCompare Wellington Partners head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
from public registers and its siteRecent portfolio activity
when companies last raised with Wellington Partners| Date | Company | Stage |
|---|---|---|
| 10 Jun 2026 | Series C+ | |
| 24 Feb 2026 | Series A | |
| 7 Aug 2025 | Series B | |
| 10 Jul 2025 | Series B | |
| 10 Sept 2024 | Series B |
Round details for Wellington Partners
Amounts, full round histories and every co-investor in Wellington Partners' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
22 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| AdrenoMed AG is a clinical-stage biopharmaceutical company that develops treatments for life-threatening conditions associated with increased vascular leakage, congestion and shock. | Healthcare & Biotech | Portfolio page | ||
| Aignostics provides AI-powered tissue analysis services for life sciences, clinical, and academic applications | Healthcare & Biotech | Portfolio page | ||
| Amboss provides a medical knowledge platform for doctors and students | Healthcare & Biotech | Portfolio page | ||
| Beren Therapeutics develops medicines to address the root cause of diseases | Healthcare & Biotech | Jun 2026Series C+ | Funding round | |
| Confo Therapeutics is a clinical-stage company committed to identifying and accelerating novel medicines for metabolic and endocrine diseases. | Healthcare & Biotech | Portfolio page | ||
| Corflow develops solutions for detecting and treating microvascular disease, specifically microvascular obstruction in heart attack patients. | Healthcare & Biotech | Sept 2024Series B | Page + round | |
| Dunad Therapeutics discovers and develops transformational medicines that selectively and durably target disease drivers | Healthcare & Biotech | Portfolio page | ||
| eGenesis develops human-compatible organs for patients with organ failure using genome engineering and transplantation | Healthcare & Biotech | Portfolio page | ||
| Immatics develops novel immunotherapies to recognize and eliminate cancer cells that present PRAME | Healthcare & Biotech | Portfolio page | ||
| Iomx is a clinical-stage biotech company that generates novel treatments for solid tumor indications | Healthcare & Biotech | Portfolio page | ||
| Koa Health provides mental health care services, including therapy and digital therapeutics, to individuals and organizations. | Healthcare & Biotech | Portfolio page | ||
| MinervaX is developing a prophylactic vaccine against Group B Streptococcus | Healthcare & Biotech | Portfolio page | ||
| The company develops and provides robotic microsurgery systems and instruments for surgeons to perform complex procedures with greater precision and control. | Healthcare & Biotech | Portfolio page | ||
| Nuclidium develops next-generation copper-based radiopharmaceuticals for the diagnosis and treatment of cancer | Healthcare & Biotech | Jul 2025Series B | Funding round | |
| The company develops and provides digital therapy solutions for neurological disorders and rehabilitation. | Healthcare & Biotech | Feb 2026Series A | Page + round | |
| Onward Delivery matches brokers with carriers to facilitate final mile logistics and delivery of big and bulky items | Legal & ComplianceE-commerce & Marketplaces | Portfolio page | ||
| Polares Medical develops a Transcatheter Leaflet Restoration system to treat Functional Mitral Regurgitation | Healthcare & Biotech | Portfolio page | ||
| SciRhom GmbH develops therapies for autoimmune diseases using humanized antibodies against iRhom2. | Healthcare & Biotech | Portfolio page | ||
| Seamless Therapeutics is developing a pipeline of disease-modifying product candidates using programmable recombinase technology to correct the genetic cause of disease | Healthcare & Biotech | Portfolio page | ||
| SNIPR BIOME develops CRISPR-powered medicines to fight resistant bacteria | Healthcare & Biotech | Aug 2025Series B | Page + round |
About this data
site last read 5 Nov 2026- Site
- wellington-partners.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 10 Sept 2024
- Companies checked
- 22
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Wellington Partners' profile as data
Pull Wellington Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/wellington-partners.com
# also
GET /v1/firms/wellington-partners.com/portfolio
GET /v1/firms/wellington-partners.com/coinvestors
GET /v1/firms/wellington-partners.com/news